JAK3 mutations exclusive to SHiGDA suggest failure of immune surveillance by the gutassociated lymphoid tissue [GALT] to recognize the malignant potential of SHiGDA allowing unimpeded progress to infiltrative cancer. Here, JAK3 is linked to cancer.